XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
3 Months Ended
Apr. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows:
Level 1    Observable inputs, such as quoted prices in active markets for identical assets or liabilities.
Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The Company uses the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
The carrying amounts of the Company’s financial instruments, which include cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value because of the short maturity of those instruments.
The following tables present the fair value of the Company’s financial assets measured at fair value on a recurring basis, based on the three-tier fair value hierarchy (in thousands):
As of April 30, 2022
Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$69,842 $— $— $69,842 
Corporate debt securities— 427 — 427 
Marketable securities:
U.S. Treasury securities— 66,498 — 66,498 
Corporate debt securities— 168,886 — 168,886 
Commercial paper— 24,906 — 24,906 
Foreign government obligations— 7,534 — 7,534 
Supranational securities— 8,915 — 8,915 
Certificates of deposit— 2,444 — 2,444 
Total financial assets$69,842 $279,610 $— $349,452 
As of January 31, 2022
Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$70,742 $— $— $70,742 
Marketable securities:
U.S. Treasury securities— 67,476 — 67,476 
Corporate debt securities— 167,160 — 167,160 
Commercial paper— 19,033 — 19,033 
Foreign government obligations— 7,607 — 7,607 
Supranational securities— 12,922 — 12,922 
Certificates of deposit— 2,313 — 2,313 
Total financial assets$70,742 $276,511 $— $347,253 
The Company had $0.3 million of restricted cash invested in money market funds that is not included in the tables above as of April 30, 2022 and January 31, 2022, respectively.
In connection with the Loan and Security agreement, discussed in Note 6, the Company issued 32,276 warrants to purchase shares of the Company’s redeemable convertible preferred stock. The Company used a Black-Scholes option valuation model to value its redeemable convertible preferred stock warrant liability at inception and on subsequent valuation dates. Changes in the fair values of the redeemable convertible preferred stock warrant liability were recorded as interest and other income (expense), net in the Company’s condensed consolidated statements of operations. All 32,276 warrants to purchase shares of redeemable convertible preferred stock converted into warrants to purchase common stock upon the closing of the Company’s IPO and the related liability was reclassified to additional-paid in capital in the Company’s condensed consolidated balance sheet. During the three months ended April 30, 2022, no warrants were exercised. During the three months ended April 30, 2021, 21,746 warrants were exercised. There were no transfers between levels of the fair value hierarchy during the three months ended April 30, 2022 and 2021, respectively.
The following is a summary of available-for sale marketable securities, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheet as of April 30, 2022 and January 31, 2022, respectively (in thousands):
As of April 30, 2022
Amortized CostUnrealized GainUnrealized LossFair Value
U.S. Treasury securities$67,108 $— $(610)$66,498 
Corporate debt securities170,192 3 (1,309)168,886 
Commercial paper25,002 — (96)24,906 
Foreign government obligations7,607 — (73)7,534 
Supranational securities8,915 — — 8,915 
Certificates of deposit2,460 — (16)2,444 
Total marketable securities$281,284 $3 $(2,104)$279,183 
As of January 31, 2022
Amortized CostUnrealized GainUnrealized LossFair Value
U.S. Treasury securities$67,770 $— $(294)$67,476 
Corporate debt securities167,693 3 (536)167,160 
Commercial paper19,052 — (19)19,033 
Foreign government obligations7,640 — (33)7,607 
Supranational securities12,923 — (1)12,922 
Certificates of deposit2,319 — (6)2,313 
Total marketable securities$277,397 $3 $(889)$276,511 
The Company does not believe that any unrealized losses are attributable to credit-related factors based on its evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to an issuer of a security or its industry. No impairment loss has been recorded on the securities included in the table above, as the Company believes that the decrease in fair value of these securities is temporary.
The following table presents the contractual maturities of the Company’s marketable securities (in thousands):
April 30,
2022
Due in one year or less$228,406 
Due after one year and within five years50,777 
Total marketable securities$279,183